NeuroThera Labs Inc. Stock: price and insider trades · Canada
NeuroThera Labs Inc.: what insiders have been doing
NeuroThera Labs Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEDI. In the past year (22 October 2025 to 22 October 2026), 3 filings came from 2 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Compared with its exchange (2,472 companies, median 12 filings), a count of 3 filings is below the norm.
Insider buying of NeuroThera Labs Inc. has been absent for the past year. The median gap between a trade and its publication by SEDI is 1 day. This delay matters because a trade only becomes useful information once it is public.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 22,500,000 sharesWarrantsTSXSEDI:4766042
- 22,500,000 shares@ CA$0.120.73% mcap100.0% of flowCommon SharesTSXSEDI:4766041
- 166,650 shares@ CA$0.10100.0% of flowCommon SharesTSXSEDI:4597526
3 of 3 declarations
About NeuroThera Labs Inc.
NeuroThera Labs Inc. is a company focused on developing innovative therapies for neurological disorders. It is listed on the Toronto Stock Exchange.
